Type
|
Date
|
Title
|
Description
|
ID
|
| Invited presentations at conferences |
2020-03-05 |
Pharmaceutical Data in the Light of the General Data Protection Regulation: Legal Challenges for Health and Genetic Data resulting from Innovations in Biotechnology and Bioinformatics |
Annual Conference «EU Law in the Pharmaceutical Sector 2020», Europäische Rechtsakademie (ERA) Brüssel |
4615791 |
| Invited presentations at conferences |
2020-03-06 |
WHO Resolution on Transparency |
Annual Conference «EU Law in the Pharmaceutical Sector 2020», Europäische Rechtsakademie (ERA) Brüssel |
4615792 |
| Invited presentations at conferences |
2020-10-23 |
Technology Transfer and Licensing of Genetic Resources |
Schwedisches Patentamt / Patent and Registration Office (PRV) in Kooperation mit der Weltorganisation für Geistiges Eigentum (WIPO) |
4615794 |
| Invited presentations at conferences |
2020-11-12 |
The Revised Swiss Therapeutics Products Act: Integrity and Transparency Rules for a Late Industry? |
Annual General Meeting, Ethics and Compliance Switzerland (ECS) |
4615796 |
| Invited presentations at conferences |
2019-11-26 |
Die Sicherheitsmerkmale für die Verpackung von Humanarzneimittel nach der Verordnung (EU) 16/2016 und Schutz vor Arzneimittelfälschungen |
Arbeitsgemeinschaft für pharmazeutische Verfahrenstechnik (APV) und Schweizerisches Verpackungsinstitut (SVI) |
4615797 |
| Invited presentations at conferences |
2019-11-25 |
Editing the Code of Human Life - Legal Questions and Ethical Thoughts for a Regulatory Framework of Genome Editing |
Universitäre Veranstaltung des Institut für Zellbiologie |
4615798 |
| Invited presentations at conferences |
2019-11-18 |
Personalized Medicine and Genomic Data: Challenges for new Regulatory Pathways between Scientific Advance and Data Protection in National and International Law |
Conference «Paving the way for personalized personalized medicine» |
4615799 |
| Invited presentations at conferences |
2019-10-03 |
Data Protection in Pre- and Post-Market Research in the Life Sciences Sector – Legal Aspects of the General Data Protection Regulation for the Treatment of Patients Data by the Life Sciences Industry and the Providers of Healthcare Services |
Tagung «Aktuelle Entwicklung im Bereich Life Sciences» |
4615800 |
| Invited presentations at conferences |
2019-09-27 |
Protection of Genetic Material and Information in the Pharmaceutical Sector? – Legal Questions on Genetic Material and Genome Sequencing between Innovation, Protection and Sharing |
7th Conference of the European Association of Health Law (EAHL) |
4615801 |
| Invited presentations at conferences |
2019-06-28 |
Strong and Weak Rights and the Challenge of Assumptions: How to Assess the Anti-Competitive Effects of Settlement Agreements in the Pharmaceutical Sector if you don´t know the Value of the Patent |
ASCOLA Konferenz «Challenges to the Assumptions at the Basis of Competition Law» |
4615802 |
| Invited presentations at conferences |
2019-06-15 |
Who owns the Data? – Access, Control, Ownership and Lawful Use of Data and Artificial Intelligence of Digitalized Medicine |
Bernd Spiessl-Symposium «Digital Future of Medicine / Artificial Intelligence» |
4615804 |
| Invited presentations at conferences |
2019-05-22 |
International Law and Marine Genetic Resources at the Crossroads: Legal Challenges in the Regulation and Protection of Genetic Material and Data |
Konferenz «Marine Genetic Resources in Areas beyond National Jurisdiction: Bridging Policy, Law, Science and Research and Development» |
4615805 |
| Invited presentations at conferences |
2019-04-10 |
Historical Paradigm Shift from Material to Data – Does the Current Intellectual Property System works or do we need a Protection sui generis? |
Tagung «Digital Sequencing of Genetic Resources – Need for Regulation?» |
4615806 |
| Invited presentations at conferences |
2019-03-07 |
Digital Sequence Information and Synthetic Biology – Intellectual Protection of Genetic Material and Genetic Information and Legal Challenges for Access and Benefit Sharing |
Konferenz «Genetic Resources, who benefits?», Intellectual Property Awareness Network (IPAN) |
4615807 |
| Invited presentations at conferences |
2019-02-27 |
Artificial Intelligence, Data Protection and Pharmaceutical Data |
Tagung «Big Data in the Pharmaceutical Sector between Protection and Transparency: Opportunities and Legal Challenges» |
4615808 |
| Invited presentations at conferences |
2019-02-26 |
The Rising Storm – Challenges of Genome Editing and CRISPR/Cas 9 for the Life Sciences Law |
Basel Chapter Life Sciences Innovation Networking Apero, British Swiss Chamber of Commerce (BSCC) |
4615810 |
| Invited presentations at conferences |
2018-11-29 |
Digitization of Healthcare between Transparency and Data Protection - Legal Questions concerning Open Data, Patient Privacy, Utilization and Ownership of Health Data |
Digital Ethics Symposium, Universität Basel |
4615811 |
| Invited presentations at conferences |
2018-11-15 |
Big Data and Genome Sequencing: Legal Issues and Questions |
Tagung «Technology Transfer and Access and Benefit Sharing for Genetic Resources» |
4615812 |
| Invited presentations at conferences |
2018-11-06 |
NBT-Derived Plants: GMOs – or something else? |
Konferenz «Genome Editing under Gene Technology Law» |
4615813 |
| Invited presentations at conferences |
2018-10-12 |
Modifiziert oder nicht? – Regulatorische Rechtsfragen der Gen-Optimierung durch Genome Editing |
Konferenz «Genome Editing als Herausforderung für das das Life Sciences-Recht» |
4615814 |
